Belite Bio (BLTE) Enterprise Value (2021 - 2025)
Belite Bio (BLTE) posted quarterly Enterprise Value of -$155.1 million for Q4 2025, down 328.23% year-over-year from $68.0 million in Q4 2024, and up 1.21% quarter-over-quarter from -$157.0 million in Q3 2025.
Belite Bio (BLTE) Enterprise Value (2021 - 2025) Analysis & Trends
Belite Bio's Enterprise Value history runs 5 years deep, the most recent figure standing at -$155.1 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 328.23% year-over-year to -$155.1 million; the TTM figure through Dec 2025 stood at -$155.1 million (down 328.23% YoY), while the FY2025 annual figure was -$155.1 million, down 328.23% from the prior year.
- Enterprise Value for Q4 2025 stood at -$155.1 million, up from -$157.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$17.3 million in Q4 2021, with the low at -$157.0 million in Q3 2025.
- The 5-year median for Enterprise Value is -$65.1 million (2022), against an average of -$82.7 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 58.91% in 2024, then slumped 328.23% in 2025.
- Belite Bio's Enterprise Value stood at -$17.3 million in 2021, then sank by 142.67% to -$42.1 million in 2022, then slumped by 109.45% to -$88.2 million in 2023, then jumped by 58.91% to -$36.2 million in 2024, then sank by 328.23% to -$155.1 million in 2025.
- Business Quant data shows BLTE's Enterprise Value at -$155.1 million in Q4 2025, -$157.0 million in Q3 2025, and -$36.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -155.13 Mn |
| Sep 30, 2025 | -157.03 Mn |
| Dec 31, 2024 | -36.23 Mn |
| Dec 31, 2023 | -88.16 Mn |
| Dec 31, 2022 | -42.09 Mn |
| Dec 31, 2021 | -17.34 Mn |